Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis

Sattar, N; McGuire, DK; Pavo, I; Weerakkody, GJ; Nishiyama, H; Wiese, RJ; Zoungas, S

Sattar, N (通讯作者)，Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.;Zoungas, S (通讯作者)，Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic, Australia.

NATURE MEDICINE, 2022; 28 (3): 591

Abstract

Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索